肿瘤学和血液学医疗咨询团队

联系我们

We have a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Labcorp physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. 

我们的医疗团队成员均根据临床、学术和行业经验甄选,这些经验涵盖包括儿科肿瘤学在内的大多数肿瘤学适应症。

Within this oncology medical team is a specialized team of oncology medical consultants.该团队具有特定肿瘤学适应症生命周期管理方面的专业知识,包括临床研发规划和策略、目标产品资料的建立、计划可行性、风险评估和执行、登记、计划和研究级医学监管。

他们将在整个临床过程中与您分享他们共同的专业知识,以帮助您安全有效地为肿瘤患者提供关键治疗。


认识团队成员

Ariel E. Aguiló,医学博士
高级医疗主任

Ariel Aguiló, MD, Senior Medical Director for Labcorp Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. 他为客户药物研发项目临床试验的开发和执行提供主题专业知识和支持,包括担任公司的去中心化临床试验(DCT)主题专家。 Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Labcorp.他曾在10年的时间里担任过医师、药物顾问和药物研发医疗主任等职务。 Before joining Labcorp, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Labcorp in November 2019

Ariel Aguilo

Liliana Baila,医学博士
高级医疗主任

Liliana Baila, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. 她担任客户药物研发项目的首席项目医师。Baila博士为项目团队提供医疗/科学支持,对指定项目进行医疗和安全监控,并制定和审查协议、病例报告表以及其他数据和材料。Baila博士在担任医生、研究临床医生和医疗主任方面拥有25多年经验。 Before joining Labcorp, she served as Clinical Research Physician for the European Organization for Research and Treatment of Cancer (EORTC) in Brussels.入行之初,Baila博士在罗马尼亚大学医院的新生儿科和儿科接受医师培训。 She joined Labcorp in June 2020.

Liliana Baila

Maria Ignacia Berraondo,医学博士
高级医疗主任

Maria Ignacia Berraondo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Berraondo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcrop. Berraondo博士在血液学领域拥有10多年经验,并担任医学顾问和医师,在临床研究领域拥有6年经验,包括担任临床研发总监。 Before joining Lbcrop, she served as Medical Director at IQVIA in Buenos Aires. Dr. Berraondo joined Labcrop in July 2020.

Maria Ignacia Berraondo

Stefanella Bortini,哲学博士、医学博士
高级医疗主任

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Milano, Italy. She contributes to the development of Labcorp policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Labcorp. 在加入公司之前,她曾担任米兰Chiltern International肿瘤学医学事务高级总监。她还曾在i3 Research、PRA International、Pharmacia & Upjohn和Eli Lilly任职。Bortini博士获得了意大利医学和外科检查委员会的行医执照,并持有美国ECFMG医学认证。她拥有意大利佛罗伦萨大学的医学学位,以及西北大学的生物医学工程博士学位。 She joined Labcorp in July 2019.

Stefanella Bortini

Jose Daniel Fanjul Fuente,医学博士
医学总监

Jose Daniel Fanjul Fuente, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. He provides medical and scientific guidance and support to project teams and investigative sites on clients’ drug development projects, and reviews protocols, case report forms, clinical study reports and other data and materials. Fuente博士在担任医师和临床研发医疗主任方面拥有超过10年经验,专长于肿瘤学。在担任现职之前,他曾在阿根廷布宜诺斯艾利斯担任IQVIA和Bristol Myers Squibb肿瘤学医学总监和经理职位。在Bristol Myers Squibb,Fuente博士负责领导一些科学活动,这些活动推动了肿瘤学治疗领域的产品线(NivolumabIpilimumab)。 He joined Labcorp in October 2018.

Begoña de las Heras Garcia,医学博士
高级医疗主任

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain. Begoña joined Labcorp in 2016. 她担任客户药物研发项目的项目医师,并为项目团队/业务开发团队提供医学/科学专业知识。此外,她还肩负直线管理职责,负责肿瘤学TA的一组医学博士。 She brings more than 20 years of national and international clinical oncology research experience to Labcorp.就任目前的工作岗位之前,她曾在英国Chiltern担任早期执行医疗主任。她还曾在英国的Eisai和西班牙的多家公司担任临床研究职位,包括Pivotal CRO、PharmaMar、AstraZeneca和Bristol-Myers Squibb。 She also, was oncologist consult in several hospitals in Spain, General Yagüe Hospital in Burgos, Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Begoña de las Heras Garcia

Katie L. Greenwood, MD
医学总监

Katie L. Greenwood, MD is a Medical Director, Oncology based in Princeton, New Jersey. She serves as a global lead project physician on client projects. Dr. Greenwood develops and reviews protocols, case report forms and other materials. She analyzes and reviews clinical trial reports and new drug applications. She also is responsible for medical and safety monitoring on clinical trials. Dr. Greenwood has more than eight years of experience as a pediatric physician and specializes in hematology/oncology with emphasis on bone marrow transplant, immunotherapy, and cell and gene therapy. Before joining Covance, she served on faculty at Baylor College of Medicine/Texas Children's Hospital, Houston as a pediatric hematologist-oncologist. Dr. Greenwood has won numerous awards and authored several publications, presentations, and abstracts. Dr. Greenwood joined Covance in February 2021.

Katie L. Greenwood, MD is a Medical Director, Oncology

Brian Hamilton,医学博士,哲学博士
高级医疗主任

Brian Hamilton, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Newton, Massachusetts. He serves as Labcorp Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy. 他还是客户药物研发项目的全球首席项目医师。Hamilton博士在儿科医学、免疫学、造血干细胞移植以及临床研发方面拥有35多年经验。 Before joining Labcorp, he served as Executive Medical Monitor for Chiltern International.他还曾在Galena Biopharma、AstraZeneca、Onyx Pharmaceuticals、Wyeth Oncology以及其他制药和生物技术公司担任高级医学总监、主任医师、法规事务和临床研究职位。 Dr. Hamilton joined Labcorp in August 2018.

Brian Hamilton

Konstantin Haradinov,医学博士
医学总监

Konstantin Haradinov, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Sofia, Bulgaria. He contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as global lead project physician and provides medical and safety monitoring on assigned projects; reviews medical data and provides clinical and medical expertise to project teams and other Labcorp departments, and performs safety trend analyses. Haradinov博士在临床研究领域拥有15多年经验,曾担任医学主管和医师/肿瘤科医生。 Before joining Labcorp, he served as Medical Officer, Oncology, for Chiltern International in Sofia, Bulgaria. Dr. Haradinov joined Labcorp in April 2019.

He Huang,医学博士
高级医疗主任

He Huang is Senior Director, Asia Pacific (APAC) for Labcorp Clinical Development Services, based in Shanghai, China. He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Labcorp. Before joining Labcorp, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. 他还曾在上海担任AstraZeneca呼吸高级经理,并在上海担任Roche肿瘤/胃肠道医学经理。他在AstraZeneca获得了全球冠军和中国首席执行官奖。 He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Labcorp in September 2019.

He Huang

Adrianne Kelly,医学博士
高级医疗主任

Adrianne Kelly, MD, is a Contracted Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey, and Chief Medical Officer of Jude, Peregrine and Kelly Consultants, LLC, in Bethesda, Maryland. 她担任客户药物研发项目的首席项目医师。Kelly博士提供有关方案和临床研发计划的医学/科学反馈;有关方案要求的研究中心可行性意见;对指定项目的医学监督以及对项目团队的培训。她有30多年从事血液学/肿瘤学医师、临床研究人员和药物研发人员的经验。Kelly博士拥有乔治敦大学的医学学位,并凭借在医疗保健领域的领导才能和学术成就荣获了十多个奖项。 Dr. Kelly joined Labcrop in August 2010.

Geoffrey Kannan,哲学博士、医学博士
高级医疗主任

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. Kannan博士是客户药物研发项目的全球首席项目医师,为临床试验的开发与开展提供医学专业知识和支持。 Dr. Kannan brings more than 10 years of experience as a physician and medical director to Labcorp, specializing in oncology and pediatrics. Before joining Labcorp, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children's National Medical Center.在此之前,他曾在达纳-法伯癌症研究所/波士顿儿童医院/哈佛医学院的儿科神经肿瘤学系担任儿科和儿科神经肿瘤学讲师。 The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Labcorp in November 2018.

Geoffrey Kannan

Carlo Lanza,医学博士,哲学博士
执行医疗主任

Carlo Lanza, MD, PhD, is Executive Medical Officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Labcorp clients. 他负责领导早期和转化研究早期研发项目,针对靶向疗法、小分子、生物制剂和基因疗法。Lanza博士还负责监督后期研发策略的开发、登记程序的交付和审批。他在临床研发方面拥有超过20年经验,并曾担任医师和医疗主任,专长于儿科和肿瘤学。 Before joining Labcorp, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland.Lanza博士还曾在Novartis Oncology、Pfizer全球研发和AstraZeneca英国分公司担任领导职务。 Carlo joined Labcorp in 2012.

Carlo Lanza

Wojciech Massalski,医学博士
医学总监

Wojciech Massalski, MD, is Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom. 他担任客户项目的全球首席项目医生,为临床试验的开发和开展提供医学专业知识和支持。其中包括审查研究中心的可行性和招募试验对象,以及对分配的项目进行可行性风险评估和数据安全监控。Massalski博士有20多年担任医师、临床研究人员和医疗主任的经验。 Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK.他还曾在英国的Pfizer和Synexus Limited担任临床研究和医学监测职位。 Dr. Massalski joined Labcorp in April 2019.

Maria Mateo,医学博士
高级医疗主任

Maria Mateo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Mateo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. Mateo博士在担任医师、临床研究人员和医学总监方面拥有超过30年经验,之前曾在AMGEN、Boehringer-Ingelheim、IQVIA、IVAX Argentina、Syneos Health、Bristol-Myers Squibb以及其他药物研发和卫生保健组织任职。 Dr. Mateo joined Labcorp in November 2020.

Maria Mateo

Valery Novikov,医学博士,哲学博士
高级医疗主任

Valery Novikov, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France. 她负责医疗策略和客户临床研究项目的执行。Novikov博士审查方案、病例报告表、临床试验报告、新药申请、实验室价值、不良事件、数据表以及其他数据和材料。她还负责指定项目的医疗和安全监测。 She brings more than 20 years of national and international clinical research experience to Labcorp. Before joining Labcorp, Dr. Novikov served as Clinical Study Director for Sanofi in France.他还曾在俄罗斯莫斯科的Generium、Helios Clinical Research和PRA International担任临床研究职位。 Dr. Novikov joined Labcorp in August 2019.

Martine Poelman,医学博士
执行医疗主任

Martine Poelman is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Labcorp clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Labcorp. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Labcorp, providing medical monitoring for more than 200 clinical trials. Before joining Labcorp, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. 在进入研究界之前,她曾在荷兰Wilhelmina儿童医院的小儿肿瘤科担任骨髓移植和血液肿瘤医师。 Martine joined Labcorp in November 1996.

Martine Poelman

Chia Portera,医学博士,哲学博士
高级医疗主任

Chia Portera, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey. 她为客户的临床研究项目评估并制定药物开发策略,并为项目团队提供科学/临床专业知识。Portera博士开发、审查和修订方案、临床试验报告、新药申请以及其他数据和文件,并负责对指定项目进行医疗和安全监控。她有超过10年担任临床研究和开发医学肿瘤学家和医疗主任的经验。 As a medical director at Genentech before joining Labcorp, Dr. Portera led clinical development strategies of post-market therapies for treatment of HER2+ breast cancer. She joined Labcorp in July 2015.

Chia Portera

Kamal Veer Singh Saini,医学博士
执行医疗主任

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. Kamal是一名获得专业认证的医学肿瘤学家,并拥有在英国执业的有效执照。 He contributes to the scientific strategic leadership of the Oncology area at Labcorp, and provides clinical and medical expertise to project teams and other Labcorp departments on clients' drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Labcorp.他之前曾担任一家学术研究组织的副科学总监,并担任布鲁塞尔朱尔斯·博尔代特研究所的医学顾问。 The author or co-author of several peer-reviewed journal articles, Kamal joined Labcorp in June 2015.

Kamal Veer Singh Saini

Chiara Sguotti,医学博士
高级医疗主任

Chiara Sguotti, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Milano, Italy. She is responsible for all medical activities related to clients' drug development projects. Sguotti博士为项目团队提供医学专业知识、审查方案以及其他数据和材料,并为分配的项目提供医学和安全性监控。她拥有超过20年的临床开发和医疗事务经验,负责实施和管理I至III期实体瘤试验,并参与开发不同种类的药物,例如化疗、内分泌、生物和免疫化合物。 Before joining Labcorp, Dr. Sguotti held senior positions with Merck Seronno and Novartis AG in Switzerland, and Sanofi-Aventis, Pharmacia and Upjohn, and Sandoz in Italy. She joined Labcorp in January 2013.

Ivana Teodorovic,医学博士
高级医疗主任

Ivana Teodorovic, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Labcorp clients. 她负责开发、审查和修订研究方案,并协调和执行医疗监测以及患者数据审查。Teodorovic博士在30多年的时间里曾担任医师和药物研发医疗主任。 Before joining Labcorp, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy.初入职场时,Teodorovic博士是塞尔维亚贝尔格莱德肿瘤与放射学研究所一名经过专业认证的解剖病理学家。 She joined Labcorp in May 2005.

Ivana Teodorovic

Laura Vidal,医学博士
执行医疗主任

Laura Vidal, MD, is Executive Medical Director for Labcorp Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. Vidal博士在担任医生、临床肿瘤学家和医学总监方面拥有15多年经验。 Before joining Labcorp, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona.Vidal博士是多篇同行评审期刊论著的著作者和合著者,并曾获得多项健康和研究奖项。 She joined Labcorp in December 2020.

Laura Vidal

Ronald Walls, MD, MBA
高级医疗主任

Ronald Walls, MD, MBA, is Senior Medical Director, Global Clinical Development, based in Princeton, New Jersey. He provides medical and safety monitoring on client projects, reviews medical data, and develops and reviews protocols, case report forms and other materials. Dr. Walls has more than 20 years of experience in the biopharma industry, holding positions of increasing responsibility at many top biopharmaceutical companies. Dr. Walls is the founder of The Alliance of Minority Medical Associations and was appointed by former President George W. Bush as Chair of Secretary of Health and Human Services Tommy Thompson's Roundtable for Disparities Affecting Men of Color. A much-requested speaker and subject matter expert on how to increase the accrual and retention of minority patients and physicians in industry-sponsored clinical research, he joined Covance in March 2021.

Ronald Walls, MD, MBA, is Senior Medical Director, Global Clinical Development,

Liang Wan,医学博士,哲学博士
医学总监

Liang Wan, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Shanghai, China. He serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects. Wan博士在担任医生、研究临床医生和医疗主任方面拥有25多年经验,拥有肿瘤学、肠胃病学和血液学方面的治疗经验。 Before joining Labcorp, he was Medical Director for IQVIA in Shanghai, serving as Global or Regional Medical Advisor on assigned projects.入行之初,他是上海交通大学瑞金医院的外科和临床研究人员。 Dr. Wan joined Labcorp in May 2019.

Liang Wan

Howard Yeh,医学博士
高级医疗主任

Howard Yeh(医学博士)现任高级医疗主任(加利福尼亚州洛杉矶),驻新泽西州普林斯顿工作。他向客户展示医疗/科学能力,并参与与项目提案相关的可行性讨论、建立客户关系、与临床试验的研究者/研究中心建立关系,并担任客户药物研发项目的首席项目医生。Yeh博士在临床研究和药物研发领域担任医疗主任超过15年。 Before joining Labcorp, he was Medical Director for Johnson and Johnson, Janssen Oncology Clinical Development Services, in Pennsylvania.他之前曾担任加利福尼亚州Amgen临床开发服务部医疗主任。 The author or co-author of nearly two dozen peer-reviewed journal articles, Dr. Yeh joined Labcorp in May 2016.

Reigetsu Yoshikawa,医学博士,哲学博士
高级医疗主任

Reigetsu Yoshikawa, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services in Osaka, Japan. She contributes to the development of medical strategies and execution of clients' clinical programs and provides medical/scientific expertise to project teams. Dr. Yoshikawa has more than 30 years of experience as a physician, medical director/advisor, and professor of medicine in Japan. Before joining Labcorp, she was Senior Medical Advisor for Eli Lilly and previously served as Senior Medical Lead for Dainippon Sumitomo Pharma in Japan. Dr. Yoshikawa has served on the editorial boards of several peer-reviewed journals and has authored or co-authored dozens of articles, presentations, and abstracts. She joined Labcorp in January 2021.

Reigetsu Yoshikawa

让我们开始对话

联系我们